Cargando…

Dalbavancin for Staphylococcus aureus Bacteremia: Are We There Yet?

Detalles Bibliográficos
Autores principales:	Mahatanan, Rattanaporn, Kang, HeeEun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167975/ https://www.ncbi.nlm.nih.gov/pubmed/37180602 http://dx.doi.org/10.1093/ofid/ofad207

Ejemplares similares

Outcomes in Patients with Staphylococcus aureus Bacteremia Treated with Dalbavancin in Clinical Trials
por: Gonzalez, Pedro L., et al.
Publicado: (2021)

2255. The Use of Dalbavancin for Staphylococcus aureus Bacteremia in Persons Who Inject Drugs (PWID)
por: Van Hise, Nicholas W, et al.
Publicado: (2019)

Evolution of Antibiotic Tolerance During Oxacillin, Daptomycin and Dalbavancin Therapy Results in Breakthrough Staphylococcus aureus Bacteremias
por: Berti, Andrew, et al.
Publicado: (2017)

1778. Same Story, Different Outbreak: Lessons from a Survey Study Investigating JYNNEOS Mpox Public Vaccination Clinic Establishment in New Hampshire
por: Kang, HeeEun, et al.
Publicado: (2023)

1829. Dalbavancin versus standard of care as directed therapy for Staphylococcus aureus bacteremia in patients unable to receive OPAT
por: Frazier, J, et al.
Publicado: (2022)

1268. Dalbavancin for the Treatment of Infections due to Staphylococcus aureus
por: Streifel, Amber C, et al.
Publicado: (2020)

Interventions to treat methicillin-susceptible Staphylococcus aureus bacteremia: many methodological concerns
por: García-Perdomo, Herney Andrés, et al.
Publicado: (2019)

Dalbavancin Use for the Treatment of Methicillin-resistant Staphylococcus aureus Pneumonia
por: Barber, Katie E., et al.
Publicado: (2017)

Understanding Hyperlactatemia in Sepsis: Are We There Yet?
por: Nalos, Marek, et al.
Publicado: (2019)

Balanced Crystalloids in Sepsis: Are We There Yet?
por: Hammond, Drayton A., et al.
Publicado: (2020)

Dalbavancin Boosts the Ability of Neutrophils to Fight Methicillin-Resistant Staphylococcus aureus
por: Scutera, Sara, et al.
Publicado: (2023)

In vitro additive effects of dalbavancin and rifampicin against biofilm of Staphylococcus aureus
por: Jacob, Benjamin, et al.
Publicado: (2021)

Comparison of Sequential Dalbavancin With Standard-of-Care Treatment for Staphylococcus aureus Bloodstream Infections
por: Molina, Kyle C, et al.
Publicado: (2022)

1464. Adjuvant Systemic Steroid Therapy and Length of Hospital Stay in Pneumonia Patients: A Retrospective Cohort Study in a Community Hospital
por: Mahatanan, Rattanaporn
Publicado: (2020)

Staphylococcus aureus Bacteremia, Australia
por: Collignon, Peter, et al.
Publicado: (2005)

Staphylococcus aureus Bacteremia, Europe
por: Tiemersma, Edine W., et al.
Publicado: (2005)

Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Choo, Eun Ju, et al.
Publicado: (2016)

Dalbavancin reduces biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE)
por: Knafl, D., et al.
Publicado: (2016)

Dalbavancin is thermally stable at clinically relevant temperatures against methicillin-sensitive Staphylococcus Aureus
por: Hoyt, Aaron K., et al.
Publicado: (2023)

Dalbavancin as Secondary Therapy for Serious Staphylococcus aureus Infections in a Vulnerable Patient Population
por: Bryson-Cahn, Chloe, et al.
Publicado: (2019)

In Vitro Activity of Dalbavancin against Refractory Multidrug-Resistant (MDR) Staphylococcus aureus Isolates
por: Bongiorno, Dafne, et al.
Publicado: (2020)

Dalbavancin in the Treatment of Bacteremia and Endocarditis in People with Barriers to Standard Care
por: Ajaka, Leama, et al.
Publicado: (2020)

Persistent methicillin-resistant Staphylococcus aureus bacteremia: do we need a new therapeutic strategy?
por: Kang, Cheol-In
Publicado: (2013)

Dalbavancin for treatment of implant-related methicillin-resistant Staphylococcus aureus osteomyelitis in an experimental rat model
por: Kussmann, Manuel, et al.
Publicado: (2018)

Dalbavancin treatment of methicillin-susceptible Staphylococcus aureus pyomyositis with torpid evolution: a case report
por: Otero, Judith Álvarez, et al.
Publicado: (2019)

2671. Outcomes of Clostridium difficile Infection in Solid-Organ Transplant Patients: Nationwide Inpatient Sample 2015–2016
por: Mahatanan, Rattanaporn, et al.
Publicado: (2019)

248. Outcomes of Patients with Prosthetic Septic Arthritis with Debridement and Implant Retention
por: Mahatanan, Rattanaporn, et al.
Publicado: (2021)

1817. Characteristics and Outcomes in Patients with Staphylococcus lugdunensis Bacteremia Compared with Staphylococcus aureus and Staphylococcus epidermidis Bacteremia
por: Yukawa, Satomi, et al.
Publicado: (2022)

Future without delirium: not quite there yet but we can start by prescribing touch
por: Fernandes, Susana M., et al.
Publicado: (2022)

Staphylococcus aureus Prostatic Abscess in the Setting of Prolonged S. aureus Bacteremia
por: Eichenberger, Emily M., et al.
Publicado: (2020)

227. Staphylococcus aureus bacteremia: back to normal
por: Pedromingo Kus, Miguel Sebastian, et al.
Publicado: (2023)

Echocardiography Is Dispensable in Uncomplicated Staphylococcus aureus Bacteremia
por: Khatib, Riad, et al.
Publicado: (2013)

672 Staphylococcus aureus Bacteremia in Hospitalized Children
por: Klieger, Sarah B., et al.
Publicado: (2014)

Epidemiology of Community-Onset Staphylococcus aureus Bacteremia
por: Yarovoy, James Y., et al.
Publicado: (2019)

Antiplatelet therapy for Staphylococcus aureus bacteremia: Will it stick?
por: Tatara, Alexander M., et al.
Publicado: (2022)

We do not need a third mechanistic descriptor for chronic pain states! Not yet
por: Granan, Lars-Petter
Publicado: (2017)

Should we abandon the patient-specific instrumentation ship in total knee arthroplasty? Not quite yet!
por: Török, László, et al.
Publicado: (2021)

Phenotypic screening of resistance mechanism in Staphylococcus aureus
por: Kumar, V. Anil
Publicado: (2013)

A Narrative Review on the Role of Staphylococcus aureus Bacteriuria in S. aureus Bacteremia
por: Schuler, Franziska, et al.
Publicado: (2021)

Reevaluation of the impact of methicillin-resistance on outcomes in patients with Staphylococcus aureus bacteremia and endocarditis
por: Joo, Eun-Jeong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_iqs0lt8hhc874ibeveumu9sr7i